Other specified/unspecified inflammatory spondylopathies

M13_SPONDYLINFLAMNAS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M46.8, M46.9 Hospital discharge: ICD-9 — 720[8-9] Cause of death: ICD-10 — M46.8, M46.9 Cause of death: ICD-9 — 720[8-9] 2 out of 7 registries used, show all original rules.	2050
4. Check minimum number of events None	2050
5. Include endpoints None	2050
6. Filter based on genotype QC (FinnGen only)	2050

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	M13_SPONDYLINFLAMNAS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M46[8-9]
HD_ICD_9	720[8-9]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M46[8-9]
COD_ICD_9	720[8-9]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other specified/unspecified inflammatory spondylopathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11100	6611	4434
Only index persons	10586	6400	4186
Unadjusted period prevalence (%)
Whole population	0.16	0.19	0.12
Only index persons	0.21	0.24	0.16
Median age at first event (years)
Whole population	43.02	42.94	43.03
Only index persons	42.21	42.34	42.01

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2050	1380	670
Unadjusted period prevalence (%)	0.41	0.47	0.30
Median age at first event (years)	43.70	43.06	45.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1833: Matched controls
18329

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

52.4

323.0

1280

774

M45

ICD-10 Finland

Ankylosing spondylitis

3974.7

323.0

675

A07EC01

ATC

sulfasalazine; oral, rectal

74.9

323.0

1236

492

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

4503599627370496.0

323.0

1637

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

49.8

323.0

519

144

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

17.3

323.0

577

473

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

615.6

323.0

391

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

23.7

323.0

886

695

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

48.3

323.0

535

155

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

15.5

295.4

518

454

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

238.7

280.8

283

H02AB06

ATC

prednisolone; systemic

6.1

278.2

1275

4986

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

41.0

266.7

337

100

L88

ICPC

Rheumatoid/seropositive arthritis

26.9

266.1

376

174

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

38.4

258.7

332

105

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

787.6

217.5

210

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

19.7

216.1

338

208

M13.9

ICD-10 Finland

Arthritis, unspecified

11.4

214.9

434

487

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

17.9

212.8

345

234

L04AB04

ATC

adalimumab; parenteral

29.5

210.1

288

115

P01BA02

ATC

hydroxychloroquine; oral

9.4

197.7

446

606

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

43.9

191.3

238

L04AB01

ATC

etanercept; parenteral

39.7

187.9

239

M01AH05

ATC

etoricoxib; oral

4.3

174.2

1368

7435

M54.5

ICD-10 Finland

Low back pain

4.7

174.0

764

2421

M54.9

ICD-10 Finland

Dorsalgia, unspecified

9.6

152.4

333

414

M01AC06

ATC

meloxicam; systemic, rectal

3.9

151.5

906

3699

N02AX02

ATC

tramadol; systemic, rectal

3.9

150.2

872

3464

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

14.2

142.7

253

205

M48.0

ICD-10 Finland

Spinal stenosis

50.5

140.6

170

N03AX16

ATC

pregabalin; oral

5.0

135.4

507

1301

L04AB06

ATC

golimumab; parenteral

66.4

127.3

147

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

48.3

127.1

155

M25.5

ICD-10 Finland

Pain in joint

3.7

126.2

739

2847

M01AH01

ATC

celecoxib; oral (coxibs)

4.7

123.6

490

1319

N03AX12

ATC

gabapentin; oral

6.4

117.2

336

617

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

106.7

842

3927

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

65.8

106.4

123

L04AA13

ATC

leflunomide; oral

15.6

103.8

175

123

M54.4

ICD-10 Finland

Lumbago with sciatica

5.6

102.7

328

682

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.3

100.6

665

2706

A02BC02

ATC

pantoprazole; systemic

2.9

100.0

1244

7688

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.8

95.3

950

5044

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

7.7

94.6

234

343

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

13.2

91.8

166

137

M79.0

ICD-10 Finland

Rheumatism, unspecified

13.6

91.2

163

131

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

14.9

84.7

145

105

M03BX02

ATC

tizanidine; oral

2.6

81.3

1250

8224

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

11.9

80.2

152

138

UJF32

NOMESCO Finland

Coloscopy

3.2

79.2

506

1948

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

15.3

78.8

133

WZA10

NOMESCO Finland

Long statement of health and health related matters

18.9

78.3

122

M47.82

ICD-10 Finland

Other spondylosis, cervical region

28.0

77.1

106

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

29.4

75.9

103

L03

ICPC

Low back symptom/complaint

3.2

73.8

474

1818

A02BC03

ATC

lansoprazole; oral

2.8

70.7

560

2460

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

19.7

70.5

108

M01AB05

ATC

diclofenac; systemic, rectal

2.5

70.4

1274

8780

M03BC01

ATC

orphenadrine (citrate); systemic

2.9

68.3

529

2282

H20.1

ICD-10 Finland

Chronic iridocyclitis

24.6

67.4

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

12.5

66.2

122

104

L04AC10

ATC

secukinumab; parenteral

64.2

63.9

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

25.6

62.5

N02BE01

ATC

paracetamol; systemic, rectal

2.8

62.2

1563

12355

M01AE02

ATC

naproxen; oral, rectal

2.3

60.7

1112

7422

N06AX21

ATC

duloxetine; oral

4.1

59.2

254

695

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

94.7

58.2

M54.6

ICD-10 Finland

Pain in thoracic spine

5.9

58.2

172

316

M01AH02

ATC

rofecoxib; oral

3.9

57.1

256

727

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

575.3

56.9

N02AJ06

ATC

codeine and paracetamol; systemic

2.3

56.2

690

3763

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.0

56.0

245

681

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

33.0

55.6

L04AB05

ATC

certolizumab pegol; parenteral

36.9

55.4

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

12.8

55.2

100

N06AA09

ATC

amitriptyline; systemic

4.7

55.1

202

473

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

5.5

54.6

170

332

M54.2

ICD-10 Finland

Cervicalgia

6.0

54.5

159

287

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

54.4

M01AE03

ATC

ketoprofen; systemic, rectal

2.3

53.5

680

3751

M47.9

ICD-10 Finland

Spondylosis, unspecified

47.3

52.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

51.5

479

2242

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

11.9

51.2

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

65.3

49.5

7209X

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Unspecified inflammatory spondylopathy

+∞

49.2

M43.1

ICD-10 Finland

Spondylolisthesis

26.1

48.8

A02BC05

ATC

esomeprazole; systemic

2.2

48.7

727

4264

M79.7

ICD-10 Finland

Fibromyalgia

8.0

48.1

113

150

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.2

48.0

712

4159

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

246.3

47.2

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

47.2

466

2236

NH3EA

NOMESCO Finland

Feet X-ray examination with load

8.8

47.1

104

125

M70.6

ICD-10 Finland

Trochanteric bursitis

3.7

46.3

217

636

M46.0

ICD-10 Finland

Spinal enthesopathy

241.0

46.2

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

12.5

46.1

M54.3

ICD-10 Finland

Sciatica

8.7

45.6

101

122

A02BC01

ATC

omeprazole; systemic

2.4

45.5

488

2437

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

44.2

666

3882

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

21.0

43.8

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

9.3

43.4

103

M35.7

ICD-10 Finland

Hypermobility syndrome

14.5

43.4

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

16.0

43.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

43.2

781

4898

M79.6

ICD-10 Finland

Pain in limb

2.1

43.0

607

3431

NG1DA

NOMESCO Finland

X-ray of knees

13.7

42.9

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

5.8

42.5

126

231

M01AX17

ATC

nimesulide; oral

2.4

41.5

401

1886

J01AA02

ATC

doxycycline; systemic

2.1

41.4

1397

11089

M13.8

ICD-10 Finland

Other specified arthritis

22.1

41.1

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.2

40.9

563

3132

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

+∞

40.8

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.6

40.1

324

1376

M46.4

ICD-10 Finland

Discitis, unspecified

395.6

39.2

SPAT1249

SPAT

Treatment-related counselling outside office

2.0

39.2

728

4563

H02AB07

ATC

prednisone; oral

2.8

38.4

283

1139

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

7.5

38.0

128

M01AB55

ATC

diclofenac, combinations; oral

4.6

37.9

138

319

M01AX01

ATC

nabumetone; oral

5.7

37.4

111

204

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

23.7

37.2

L86

ICPC

Back syndrome with radiating pain

6.2

36.8

102

172

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

36.8

525

2943

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.2

36.7

205

684

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

36.6

A02BA02

ATC

ranitidine; systemic

2.5

36.3

322

1437

WZC30

NOMESCO Finland

Teaching

2.7

35.8

274

1124

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

14.7

35.6

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

33.7

35.4

SPAT1301

SPAT

No procedures

2.1

35.4

522

2957

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.2

35.3

205

703

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

35.3

362

1738

J01DB01

ATC

cefalexin; oral

2.1

35.0

1486

12363

R4110

NOMESCO Finland

Physiotherapy

2.1

34.8

466

2530

L40.5

ICD-10 Finland

Arthropathic psoriasis

9.4

33.9

XX9XE

NOMESCO Finland

Other ultrasound examination

14.7

33.8

M50.3

ICD-10 Finland

Other cervical disc degeneration

36.6

33.8

M54.1

ICD-10 Finland

Radiculopathy

10.3

33.7

M13.0

ICD-10 Finland

Polyarthritis, unspecified

12.1

33.2

R51.80

ICD-10 Finland

Headache

2.5

32.4

288

1281

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

32.4

259

1084

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

+∞

32.4

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.2

32.4

365

1827

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.1

31.8

187

646

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

31.7

371

1889

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

18.9

31.4

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

18.9

31.4

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

31.3

L04AX01

ATC

azathioprine; systemic

4.1

31.3

126

321

NF1AA

NOMESCO Finland

Hip X-ray examination

4.1

31.2

127

327

H57.1

ICD-10 Finland

Ocular pain

5.7

30.9

166

M54

ICD-10 Finland

Dorsalgia

2.8

30.8

214

823

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

12.0

30.5

7208A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Other inflammatory spondylopathies

+∞

30.3

J01FF01

ATC

clindamycin; systemic

2.0

30.1

489

2848

R06.0

ICD-10 Finland

Dyspnoea

2.2

29.9

365

1887

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

6.5

29.8

126

M01AE01

ATC

ibuprofen; systemic, rectal

2.4

29.3

1667

14837

R03AC02

ATC

salbutamol; inhalant

1.8

29.3

929

6770

SPAT1263

SPAT

Sampling

1.8

29.2

727

4907

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

57.7

29.2

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

29.1

443

2507

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.5

28.9

140

418

ZX120

NOMESCO Finland

Intravenous

2.8

28.8

196

744

G44.2

ICD-10 Finland

Tension-type headache

2.5

28.8

250

1094

M02AA07

ATC

piroxicam; topical

1.9

28.7

556

3441

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

7.5

28.4

R50.9

ICD-10 Finland

Fever, unspecified

2.4

28.0

258

1164

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

285.7

27.8

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

11.4

27.6

M01AB08

ATC

etodolac; oral

3.2

27.6

151

495

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

27.5

564

3547

L04AA11

ATC

[U] etanercept; parenteral

23.4

27.5

J01MA02

ATC

ciprofloxacin; systemic

1.8

27.5

605

3903

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.9

27.2

172

623

G54.0

ICD-10 Finland

Brachial plexus disorders

7.8

27.1

S01FA04

ATC

cyclopentolate; ophthalmic

10.1

27.0

J01DA01

ATC

[U] cefalexin; systemic

1.7

27.0

1097

8524

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

26.8

368

1990

H04.10

ICD-10 Finland

Dry eye syndrome

2.7

26.5

191

751

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

26.4

371

2024

TNG10

NOMESCO Finland

Puncture of knee

10.7

26.3

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

26.3

316

1614

M01CB01

ATC

sodium aurothiomalate; parenteral

9.9

26.3

A07EC02

ATC

mesalazine; oral, rectal

3.3

26.1

136

430

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.6

26.1

121

349

L02

ICPC

Back symptom/complaint

2.9

25.8

171

638

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

22.2

25.7

Z50.1

ICD-10 Finland

Other physical therapy

4.1

25.5

103

263

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

14.8

25.2

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

20.9

25.2

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

+∞

25.1

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

8.0

25.0

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

24.9

288

1443

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

14.3

24.9

L01

ICPC

Neck symptom/complaint

2.4

24.7

229

1030

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

11.5

24.7

N02AC04

ATC

dextropropoxyphene; oral

7.1

24.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

24.6

153

548

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.4

24.5

225

1007

E0000UV

ATC

1.7

24.5

697

4829

M01CB03

ATC

auranofin; oral

20.4

24.3

J01CA04

ATC

amoxicillin; systemic

1.8

24.3

1473

12675

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.3

23.9

237

1104

SPAT1153

SPAT

Removal of sutures

1.9

23.8

455

2771

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

23.8

210

922

R42

ICD-10 Finland

Dizziness and giddiness

2.1

23.5

298

1551

H02AB04

ATC

methylprednisolone; systemic

2.2

23.4

252

1222

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

23.2

412

2442

NF1DA

NOMESCO Finland

X-ray of hips

8.2

23.2

N02AA05

ATC

oxycodone; systemic

2.6

23.2

177

716

L84

ICPC

Back syndrome without radiat pain

4.2

23.2

227

SPAT1260

SPAT

Consultation of another employee

2.1

23.0

281

1436

M02AA10

ATC

ketoprofen; topical

2.2

23.0

254

1244

9211

FHL

Exploration or removal of diskusprolapse

+∞

23.0

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

23.0

ZX140

NOMESCO Finland

Intra articular

11.3

22.9

P01AB01

ATC

metronidazole; oral, rectal

1.7

22.9

694

4868

D07AC01

ATC

betamethasone; topical

1.7

22.8

555

3648

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

6.4

22.5

K02.1

ICD-10 Finland

Caries of dentine

1.6

22.4

1061

8386

M01AH03

ATC

valdecoxib; oral

3.2

22.4

122

399

L28

ICPC

Limited function/disability (L)

2.5

22.2

190

822

4AB02

NOMESCO Finland

19.7

22.2

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

22.1

1191

9725

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

+∞

21.9

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

10.7

21.9

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

21.8

296

1579

Z71.8

ICD-10 Finland

Other specified counselling

1.8

21.8

432

2651

C07AB07

ATC

bisoprolol; oral

1.7

21.8

593

4018

M43.0

ICD-10 Finland

Spondylolysis

39.1

21.7

M54.8

ICD-10 Finland

Other dorsalgia

4.9

21.7

152

M07.3

ICD-10 Finland

Other psoriatic arthropathies

10.5

21.6

S18

ICPC

Laceration/cut

1.7

21.6

611

4183

SPAT1310

SPAT

Counselling related to known health issue

1.7

21.6

513

3338

R03AC03

ATC

terbutaline; inhalant

2.1

21.5

260

1322

L17

ICPC

Foot/toe symptom/complaint

1.9

21.5

378

2225

J01FA10

ATC

azithromycin; systemic

1.6

21.2

1063

8469

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.9

21.2

147

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.6

21.1

278

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.3

21.1

215

1011

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.2

21.1

117

388

R01AD09

ATC

mometasone; nasal

1.6

21.0

825

6163

WX110

NOMESCO Finland

Local anesthesy

1.6

21.0

1229

10181

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

+∞

20.9

A01

ICPC

Pain general/multiple sites

3.1

20.8

121

414

M79.1

ICD-10 Finland

Myalgia

2.2

20.8

218

1038

M01AC01

ATC

piroxicam; systemic, rectal

2.3

20.8

209

979

H15.1

ICD-10 Finland

Episcleritis

6.6

20.6

B01AB05

ATC

enoxaparin; parenteral

1.8

20.6

437

2738

N06AX11

ATC

mirtazapine; oral

1.7

20.5

506

3319

SPAT1202

SPAT

Intra-articular injection

5.3

20.4

123

M01AE52

ATC

naproxen and esomeprazole; oral

4.3

20.4

181

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

20.3

266

1401

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

8.5

20.2

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.5

20.2

294

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

19.8

631

4442

N06AX16

ATC

venlafaxine; oral

2.1

19.6

251

1308

M76.6

ICD-10 Finland

Achilles tendinitis

4.2

19.4

185

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

14.8

19.4

L99

ICPC

Musculoskeletal disease other

6.4

19.3

M06

ICD-10 Finland

Other rheumatoid arthritis

15.7

19.3

L20

ICPC

Joint symptom/complaint NOS

4.1

19.3

196

N05BA01

ATC

diazepam; systemic, rectal

2.2

19.2

214

1047

AA1AD

NOMESCO Finland

CT of head and brain

2.0

19.1

285

1574

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

19.1

1046

8414

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

19.0

692

5033

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

5.6

18.8

101

R52.2

ICD-10 Finland

Other chronic pain

4.8

18.8

135

M35.3

ICD-10 Finland

Polymyalgia rheumatica

5.1

18.7

118

M53.2

ICD-10 Finland

Spinal instabilities

70.6

18.7

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.0

18.7

113

397

G47.3

ICD-10 Finland

Sleep apnoea

1.9

18.7

322

1872

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

101.1

18.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

18.6

1266

10704

R03DC03

ATC

montelukast; oral

1.9

18.5

286

1597

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.6

18.5

136

539

A07EA06

ATC

budesonide; oral, local oral

3.8

18.5

219

K07.60

ICD-10 Finland

Snapping jaw

2.9

18.4

113

402

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

18.4

305

1752

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

5.3

18.4

108

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

44.5

18.2

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

11.6

18.0

R4120

NOMESCO Finland

Occupational therapy

2.8

18.0

118

437

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

53.1

18.0

M02.8

ICD-10 Finland

Other reactive arthropathies

18.2

17.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

17.8

270

1501

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

17.7

820

6286

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.3

17.7

280

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

+∞

17.7

J01FA06

ATC

roxithromycin; oral

1.6

17.6

670

4897

J02AC01

ATC

fluconazole; systemic

1.6

17.6

743

5572

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.2

17.6

168

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

29.1

17.4

M01AB01

ATC

indometacin; systemic, rectal

3.0

17.4

101

346

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

42.4

17.3

XA402

NOMESCO Finland

ENMG

5.4

17.3

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

7.5

17.2

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

17.1

959

7664

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

17.1

172

802

M77.9

ICD-10 Finland

Enthesopathy, unspecified

4.2

17.0

159

R52.9

ICD-10 Finland

Pain, unspecified

2.6

17.0

127

507

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

16.9

139

585

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.7

16.9

205

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

19.5

16.9

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.6

16.8

222

L13

ICPC

Hip symptom/complaint

2.1

16.7

192

951

ZXA05

NOMESCO Finland

Left side

1.8

16.3

346

2147

H02BX01

ATC

methylprednisolone, combinations; systemic

3.7

16.2

202

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

16.1

175

848

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

7.8

15.9

M02.3

ICD-10 Finland

Reiter disease

60.5

15.8

SPAT1229

SPAT

Assessment of need for aid

3.0

15.8

332

M46

ICD-10 Finland

Other inflammatory spondylopathies

+∞

15.6

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

7.2

15.6

L04AA17

ATC

[U] adalimumab; parenteral

19.4

15.6

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

15.6

921

7387

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

161.3

15.5

N05CF01

ATC

zopiclone; oral

1.6

15.5

442

2981

R01AD12

ATC

fluticasone furoate; nasal

1.6

15.5

551

3936

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.6

15.4

115

462

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.9

15.4

340

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.8

15.3

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

8.4

15.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

15.2

874

6950

L04AA01

ATC

[U] ciclosporin; systemic

6.1

15.2

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

15.1

103

392

S01FA02

ATC

scopolamine; ophthalmic

7.9

15.1

R06AE07

ATC

cetirizine; oral

1.5

15.1

752

5797

M05BA04

ATC

alendronic acid; oral

2.8

15.0

364

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

14.9

454

3114

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

14.8

152

717

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

14.8

113

457

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

8.1

14.6

J01FA09

ATC

clarithromycin; systemic

1.6

14.5

531

3804

M02.1

ICD-10 Finland

Postdysenteric arthropathy

14.3

14.5

M25.9

ICD-10 Finland

Joint disorder, unspecified

7.3

14.5

WZA90

NOMESCO Finland

Other doctors statement

1.7

14.5

373

2444

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.9

14.5

301

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

36.3

14.4

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

5.2

14.4

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

15.5

14.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

14.3

284

1722

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

14.3

506

3597

ZXA00

NOMESCO Finland

Right side

1.7

14.3

359

2335

WX002

NOMESCO Finland

Sedation and analgesia

1.8

14.3

274

1645

C07AB02

ATC

metoprolol; systemic

1.9

14.2

230

1303

L16

ICPC

Ankle symptom/complaint

2.2

14.1

154

747

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

14.0

387

2580

C03CA01

ATC

furosemide; systemic

1.8

13.9

259

1539

R01AD08

ATC

fluticasone; nasal

1.6

13.8

500

3564

WX290

NOMESCO Finland

Other blockade of nerve

1.5

13.8

816

6478

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

24.0

13.8

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.1

13.7

154

755

H20

ICD-10 Finland

Iridocyclitis

13.7

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

13.7

127

570

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

13.7

151

733

L04AD01

ATC

ciclosporin; systemic

4.8

13.7

L08

ICPC

Shoulder symptom/complaint

1.8

13.6

245

1437

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

5.4

13.6

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

14.8

13.6

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

13.6

675

5164

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

13.6

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

13.5

225

1284

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.7

13.5

350

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

34.3

13.5

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

13.5

154

759

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.5

13.5

111

468

4AB0M

NOMESCO Finland

141.0

13.5

ZYC01

SPAT

2.4

13.4

119

523

N02AJ13

ATC

tramadol and paracetamol; systemic

5.4

13.3

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.9

13.3

C07AA05

ATC

propranolol; systemic

1.7

13.3

321

2060

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

13.2

821

6563

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.3

13.2

210

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.6

13.2

368

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.6

13.2

439

3064

ACC51

NOMESCO Finland

Release of median nerve

2.4

13.2

115

501

R07.3

ICD-10 Finland

Other chest pain

2.3

13.1

128

590

C01CA24

ATC

epinephrine; parenteral

2.3

13.0

123

558

SPAT1312

SPAT

General health counselling

1.5

13.0

495

3561

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

4.9

13.0

L15

ICPC

Knee symptom/complaint

1.7

13.0

280

1738

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.1

13.0

153

768

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

12.9

376

2536

J35.0

ICD-10 Finland

Chronic tonsillitis

2.3

12.9

117

521

J04AB02

ATC

rifampicin; systemic

7.7

12.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.6

12.9

161

N05BA04

ATC

oxazepam; oral

1.6

12.8

378

2556

K50.0

ICD-10 Finland

Crohn disease of small intestine

4.9

12.8

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

12.8

168

878

R03BA02

ATC

budesonide; inhalant

1.7

12.8

280

1746

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

12.7

197

1098

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

9.7

12.7

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

12.7

195

1084

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.2

12.7

131

621

S06.0

ICD-10 Finland

Concussion

2.1

12.7

149

747

D07XC01

ATC

betamethasone, combinations; topical

1.9

12.6

183

995

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

12.4

12.6

M46.2

ICD-10 Finland

Osteomyelitis of vertebra

+∞

12.5

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

12.5

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

130.9

12.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

12.4

135

652

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.6

12.4

156

D07AD01

ATC

clobetasol; topical

1.8

12.3

240

1442

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

3.7

12.3

147

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

12.2

425

2990

C10AC01

ATC

colestyramine; oral

4.0

12.2

123

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.4

12.1

180

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

12.5

12.1

ZXH09

SPAT

3.4

12.1

175

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

12.1

708

5564

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

8.2

12.1

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

12.0

144

727

M01AX05

ATC

glucosamine; oral

1.8

12.0

198

1126

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

12.0

380

2612

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

12.0

313

2047

J01MA14

ATC

moxifloxacin; systemic

2.2

12.0

125

593

J05AB01

ATC

aciclovir; systemic

1.6

12.0

329

2182

A01AB09

ATC

miconazole; local oral

2.2

11.9

123

582

UJF92

NOMESCO Finland

Capsular endoscopy

4.1

11.9

111

M70.7

ICD-10 Finland

Other bursitis of hip

4.6

11.9

R74

ICPC

Upper respiratory infection acute

1.5

11.9

521

3856

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

11.9

112

507

K50.8

ICD-10 Finland

Other Crohn disease

4.3

11.9

102

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

11.8

151

782

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.7

11.8

SBB10

NOMESCO Finland

Teeth copy

2.3

11.8

106

468

SPAT1325

SPAT

Vaccination

1.5

11.8

450

3230

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.1

11.8

212

Z01.2

ICD-10 Finland

Dental examination

1.4

11.8

690

5414

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

11.7

203

1176

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.2

11.7

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

11.6

106

475

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

11.6

341

2298

M46.5

ICD-10 Finland

Other infective spondylopathies

+∞

11.5

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

11.5

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

11.5

647

5036

R06AX27

ATC

desloratadine; oral

1.5

11.4

487

3575

G06.1

ICD-10 Finland

Intraspinal abscess and granuloma

120.7

11.4

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.6

11.4

311

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.1

11.4

200

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

3.3

11.4

178

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

11.4

143

734

N03AE01

ATC

clonazepam; systemic

2.6

11.4

322

L12

ICPC

Hand/finger symptom/complaint

1.8

11.4

200

1164

N06AA10

ATC

nortriptyline; systemic

4.6

11.3

R5599

NOMESCO Finland

Other rehabilitation service

4.3

11.3

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.3

11.2

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

17.1

11.2

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

17.1

11.2

M17.5

ICD-10 Finland

Other secondary gonarthrosis

5.7

11.2

C08CA01

ATC

amlodipine; oral

1.5

11.1

390

2740

R1250

NOMESCO Finland

Evaluation of functional capability

4.2

11.1

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.2

11.1

112

522

4AA12

NOMESCO Finland

12.8

11.1

UKC02

NOMESCO Finland

Cystoscopy

1.9

11.1

165

904

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

11.1

301

1986

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

11.0

153

818

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

11.0

246

1536

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.3

11.0

104

473

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

14.0

11.0

XKD00

NOMESCO Finland

Uroflowmetry

2.0

10.9

142

744

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

10.8

200

1179

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

8.9

10.8

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

10.8

226

R03BA08

ATC

ciclesonide; inhalant

2.0

10.7

132

675

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.0

10.7

128

648

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

10.7

187

1086

UDC00

NOMESCO Finland

Ear microscopy

2.2

10.6

112

537

NDL52

NOMESCO Finland

Tenosynovectomy of hand

8.0

10.6

RF420

NOMESCO Finland

6.0

10.6

ZXA10

NOMESCO Finland

Bilateral

1.7

10.6

239

1500

R51

ICD-10 Finland

Headache

2.4

10.6

388

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.9

10.5

233

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

10.5

431

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

6.6

10.5

-1

NOMESCO Finland

1.4

10.5

573

4413

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

10.4

M48.9

ICD-10 Finland

Spondylopathy, unspecified

+∞

10.4

R05

ICD-10 Finland

Cough

1.6

10.4

266

1725

K59.1

ICD-10 Finland

Functional diarrhoea

2.6

10.4

292

X58

ICD-10 Finland

Exposure to other specified factors

1.7

10.4

208

1261

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

10.4

179

1035

R21

ICPC

Throat symptom/complaint

1.5

10.3

344

2383

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

10.7

10.3

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

23.5

10.2

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

10.2

428

3120

A03

ICPC

Fever

1.6

10.2

267

1744

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

10.2

505

3815

R02

ICPC

Shortness of breath/dyspnoea

1.9

10.1

146

793

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

10.1

202

1221

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

4.5

10.1

SPAT1081

SPAT

Cardiorespiratory global assessment

2.7

10.0

253

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

10.0

366

2590

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

3.4

10.0

136

SPAT1058

SPAT

PEF monitoring instruction

2.1

10.0

111

542

SPAT1097

SPAT

Recording of ECG

1.8

10.0

165

941

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

9.9

104

496

R00.2

ICD-10 Finland

Palpitations

2.1

9.9

111

548

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

9.9

119

602

RF120

NOMESCO Finland

6.0

9.8

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

6.0

9.8

SPAT1255

SPAT

Intravenous administration of medicine

2.3

9.8

423

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

3.3

9.8

144

A02BX02

ATC

sucralfate; oral

3.0

9.7

183

E000001

ATC

1.5

9.7

321

2221

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

6.2

9.7

L34

ICPC

Musculoskeletal, Blood test

55.3

9.6

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

55.3

9.6

K80

ICPC

Cardiac arrhythmia NOS

2.2

9.6

421

K30

ICD-10 Finland

Functional dyspepsia

1.9

9.6

147

813

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

9.6

613

4844

K51.5

ICD-10 Finland

Left sided colitis

2.8

9.6

218

RF410

NOMESCO Finland

6.4

9.6

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

9.5

349

2469

N06AB04

ATC

citalopram; systemic

1.5

9.5

320

2218

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

9.5

418

3074

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.1

9.5

106

521

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

9.4

114

579

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

100.5

9.4

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

17.6

9.4

L04AC13

ATC

ixekizumab; parenteral

17.6

9.4

M25.4

ICD-10 Finland

Effusion of joint

5.2

9.4

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

+∞

9.4

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

+∞

9.4

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

+∞

9.4

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

9.4

140

772

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.5

9.3

291

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.1

9.3

166

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

9.2

600

4743

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.3

9.2

R09

ICPC

Sinus symptom/complaint

1.9

9.2

130

700

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

4.1

9.2

KMAK

NOMESCO Finland

1.4

9.1

919

7810

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

9.1

424

J45

ICD-10 Finland

Asthma

1.9

9.1

143

798

R06AX13

ATC

loratadine; oral

1.6

9.1

266

1782

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

6.3

9.1

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

11.5

9.1

SPAT1131

SPAT

Colonoscopy

3.1

9.0

153

C01DA14

ATC

isosorbide mononitrate; oral

2.0

9.0

109

554

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

36.9

9.0

N04BC05

ATC

pramipexole; oral

2.3

9.0

354

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

9.0

148

842

G44.8

ICD-10 Finland

Other specified headache syndromes

4.9

9.0

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

6.1

8.9

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

8.9

271

J20

ICD-10 Finland

Acute bronchitis

1.9

8.9

136

755

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

8.9

242

1594

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.2

8.9

403

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

8.9

159

930

A02BB01

ATC

misoprostol; oral

12.6

8.9

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.4

8.9

456

3451

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.4

8.8

320

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

8.8

247

1637

L04AC07

ATC

tocilizumab; parenteral

10.7

8.8

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

8.8

105

532

RK220

NOMESCO Finland

9.5

8.8

TAB00

NOMESCO Finland

Lumbar puncture

2.4

8.8

302

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

6.0

8.8

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

6.0

8.8

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

8.7

250

J05AB11

ATC

valaciclovir; oral

1.7

8.7

199

1250

R4180

NOMESCO Finland

Podiatric therapy

4.9

8.7

M03.2*A04.6

ICD-10 Finland

Postinfectious arthropathy in enteritis due to Yersinia enterocolitica

50.2

8.7

OAA65

SPAT

1.7

8.7

184

1131

D01

ICPC

Abdominal pain/cramps general

1.8

8.7

152

882

M04AA01

ATC

allopurinol; systemic

2.0

8.7

115

608

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

8.6

264

1788

VALMI

NOMESCO Finland

1.4

8.6

411

3065

M16.7

ICD-10 Finland

Other secondary coxarthrosis

7.7

8.6

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

8.6

289

2000

K29.7

ICD-10 Finland

Gastritis, unspecified

3.1

8.6

153

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

8.6

118

629

M53.9

ICD-10 Finland

Dorsopathy, unspecified

11.6

8.6

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

8.6

910

7767

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.8

8.6

198

N07CA01

ATC

betahistine; oral

2.1

8.5

420

R03AC13

ATC

formoterol; inhalant

2.4

8.5

293

A07EA02

ATC

hydrocortisone; rectal

3.1

8.5

149

R53

ICD-10 Finland

Malaise and fatigue

1.5

8.5

268

1830

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

8.5

488

ZXH06

SPAT

3.1

8.4

144

R03BA05

ATC

fluticasone; inhalant

1.5

8.4

266

1814

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.9

8.4

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

90.5

8.4

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.0

8.4

492

R03BA01

ATC

beclometasone; inhalant

1.7

8.4

194

1223

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.9

8.4

J45.8

ICD-10 Finland

Mixed asthma

3.1

8.4

145

S01BC03

ATC

diclofenac; ophthalmic

3.0

8.3

151

NA6AG

NOMESCO Finland

+∞

8.3

4AB0X

NOMESCO Finland

+∞

8.3

SPAT1240

SPAT

Therapeutic discussion

1.7

8.3

173

1060

D07AC13

ATC

mometasone; topical

1.4

8.3

429

3245

R31

ICD-10 Finland

Unspecified haematuria

2.1

8.3

473

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

8.3

112

596

M19.2

ICD-10 Finland

Other secondary arthrosis

5.5

8.3

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

7.1

8.2

WZC00

SPAT

2.3

8.2

316

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.8

8.2

148

865

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

14.5

8.2

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

8.2

119

650

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

8.2

158

944

EMB10

NOMESCO Finland

Tonsillectomy

1.9

8.2

111

591

WX780

NOMESCO Finland

Remote monitoring CPAP

2.5

8.2

260

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.1

8.2

456

L05

ICPC

Flank/axilla symptom/complaint

2.4

8.1

288

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.4

8.1

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.3

8.1

332

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

8.1

486

205

Kela drug reimbursment

Chronic hypertension

1.5

8.1

251

1707

K08.80

ICD-10 Finland

Toothache NOS

1.8

8.1

131

742

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

33.5

8.1

71599

ICD-8 Finland

Arthritis, unspecified

11.7

8.1

SPAT1254

SPAT

Administration of medicine

1.7

8.0

162

984

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

9.0

8.0

R03AK08

ATC

formoterol and beclometasone; inhalant

2.5

8.0

238

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.1

8.0

439

R05

ICPC

Cough

1.5

8.0

304

2159

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

3.0

8.0

150

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.0

8.0

496

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

8.0

297

OAB42

SPAT

2.2

8.0

384

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

7.9

523

4125

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.8

7.9

174

WX204

NOMESCO Finland

Axillary plexus blockaced

2.7

7.9

191

R10.0

ICD-10 Finland

Acute abdomen

2.7

7.9

192

F01

ICPC

Eye pain

2.8

7.9

169

N05AH04

ATC

quetiapine; oral

1.5

7.9

244

1660

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

6.1

7.8

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.2

7.8

380

R06AE09

ATC

levocetirizine; oral

1.5

7.8

245

1667

WW200

SPAT

1.7

7.8

173

1080

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

7.8

114

625

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

10.8

7.8

RT272

NOMESCO Finland

10.8

7.8

A07AA02

ATC

nystatin; oral

2.2

7.8

361

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.9

7.8

115

631

SPAT1284

SPAT

Extensive health certificate

2.9

7.7

158

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

7.7

135

783

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

7.7

268

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.4

7.7

250

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

7.7

451

M05BX04

ATC

denosumab; parenteral

2.7

7.7

182

WX320

NOMESCO Finland

Spinalanesthesy

1.5

7.7

293

2086

NBG10

NOMESCO Finland

Acromioplastia

3.7

7.7

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

4.8

7.6

J46

ICD-10 Finland

Status asthmaticus

3.4

7.6

105

XF402

NOMESCO Finland

ECG with work load test

1.9

7.6

112

613

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.9

7.6

114

629

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

7.6

151

910

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

7.6

194

1255

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.3

7.6

292

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.7

7.6

191

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.9

7.6

104

556

R51.81

ICD-10 Finland

Facial pain NOS

3.3

7.6

111

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

11.9

7.6

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.2

7.6

122

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.2

7.6

122

J01MA12

ATC

levofloxacin; systemic

1.6

7.6

219

1463

H15.0

ICD-10 Finland

Scleritis

8.9

7.5

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.2

7.5

117

D05AX52

ATC

calcipotriol, combinations; topical

2.1

7.5

409

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.3

7.5

R03BB01

ATC

ipratropium bromide; inhalant

3.0

7.5

134

E000002

ATC

1.6

7.5

176

1115

L29

ICPC

Musculoskeletal sympt/complt other

2.0

7.5

451

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

3.5

7.5

ZX114

NOMESCO Finland

Intramuscular

4.1

7.5

WX402

NOMESCO Finland

General anaesthesia

1.5

7.5

248

1709

N05CF02

ATC

zolpidem; oral

1.5

7.5

255

1771

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

7.4

127

732

M50.8

ICD-10 Finland

Other cervical disc disorders

80.4

7.4

M41.1

ICD-10 Finland

Juvenile idiopathic scoliosis

80.4

7.4

N06AB10

ATC

escitalopram; oral

1.4

7.4

323

2358

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.6

7.4

206

R75

ICPC

Sinusitis acute/chronic

2.1

7.4

357

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

7.4

459

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.3

7.4

71490

ICD-8 Finland

Other specified forms of arthritis, Arthritis postinfectiosa NUD

13.4

7.4

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

5.6

7.4

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

8.4

7.3

J01FA15

ATC

telithromycin; oral

1.7

7.3

158

977

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

7.3

521

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

+∞

7.3

7249X

ICD-9 Finland

Other and unspecified disorders of back, Other unspecified back disorders

+∞

7.3

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

7.3

H20.8

ICD-10 Finland

Other iridocyclitis

10.9

7.3

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

10.9

7.3

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

10.9

7.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

7.3

213

1427

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

9.4

7.3

R01AD11

ATC

triamcinolone; nasal

1.7

7.3

138

824

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.6

7.3

202

NH3AE

NOMESCO Finland

Feet ultrasound examination

15.8

7.2

OAB44

SPAT

2.3

7.2

279

M05BA06

ATC

ibandronic acid; systemic

4.3

7.2

E000006

ATC

1.9

7.2

105

575

M22.4

ICD-10 Finland

Chondromalacia patellae

2.4

7.2

229

M65.3

ICD-10 Finland

Trigger finger

2.3

7.2

280

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

4.1

7.2

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

7.2

408

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.4

7.2

249

1220

FHL

Arthroscopy

2.5

7.2

214

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

30.1

7.1

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

30.1

7.1

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

30.1

7.1

L11

ICPC

Wrist symptom/complaint

1.8

7.1

112

629

R13

ICD-10 Finland

Dysphagia

2.1

7.1

350

M01AB16

ATC

aceclofenac; oral

2.8

7.1

157

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.7

7.1

138

829

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

7.1

511

OAB47

SPAT

2.5

7.1

217

EGA00

NOMESCO Finland

Arthroscopy of mandibular joint

12.1

7.1

SPAT1262

SPAT

Handing over of treatment supplies

1.5

7.1

212

1428

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

7.1

460

3611

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.6

7.0

162

1021

J01FA01

ATC

erythromycin; systemic

1.5

7.0

243

1689

RF210

NOMESCO Finland

2.8

7.0

158

R07.0

ICD-10 Finland

Pain in throat

1.9

7.0

500

H30.2

ICD-10 Finland

Posterior cyclitis

10.1

7.0

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

10.1

7.0

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.1

7.0

L18

ICPC

Muscle pain

2.5

7.0

211

A06AD11

ATC

lactulose; oral

1.7

7.0

130

770

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.6

7.0

194

C08DA01

ATC

verapamil; systemic

2.6

7.0

194

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

4.0

7.0

E000007

ATC

1.9

6.9

482

R01AD01

ATC

beclometasone; nasal

1.5

6.8

238

1659

S22.3

ICD-10 Finland

Fracture of rib

2.1

6.8

355

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

6.8

406

3135

N06AX12

ATC

bupropion; oral

1.8

6.8

104

580

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.2

6.8

104

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.6

6.8

173

B01AB04

ATC

dalteparin; parenteral

2.2

6.8

299

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

11.0

6.8

M53.8

ICD-10 Finland

Other specified dorsopathies

9.3

6.8

RK210

NOMESCO Finland

9.3

6.8

0381A

ICD-9 Finland

Septicaemia, Staphylococcal septicaemia[SEPTICHAEMIA STAPHYLOCOCCUS AUREUS]

40.2

6.8

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.8

6.8

144

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

6.7

542

4392

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

6.7

116

673

N05BB01

ATC

hydroxyzine; systemic

1.9

6.7

543

A03FA02

ATC

cisapride; oral, rectal

2.0

6.7

441

C09CA01

ATC

losartan; oral

1.5

6.7

261

1861

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.8

6.7

H92.0

ICD-10 Finland

Otalgia

2.0

6.7

379

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

6.7

417

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

6.6

199

1343

D82

ICPC

Teeth/gum disease

1.3

6.6

563

4595

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

6.6

129

778

G72.9

ICD-10 Finland

Myopathy, unspecified

7.8

6.6

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.3

6.6

M01AC02

ATC

tenoxicam; systemic, rectal

2.3

6.6

246

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.9

6.5

469

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

8.7

6.5

EG1CG

NOMESCO Finland

Extensive MRI examination of mandipular joint with high intensity magnet

10.1

6.5

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

10.1

6.5

R55

ICD-10 Finland

Syncope and collapse

1.8

6.5

107

613

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

6.5

1184

10712

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.8

6.5

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

4.5

6.5

R03AC12

ATC

salmeterol; inhalant

2.3

6.5

241

M77.8

ICD-10 Finland

Other enthesopathies, not elsewhere classified

6.2

6.5

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.5

6.4

192

RS221

NOMESCO Finland

3.4

6.4

H40.0

ICD-10 Finland

Glaucoma suspect

1.9

6.4

465

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

70.1

6.4

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

70.1

6.4

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.8

6.4

137

XQ800

NOMESCO Finland

Prick test

1.7

6.4

115

677

Z56.5

ICD-10 Finland

Uncongenial work

14.4

6.4

G44.0

ICD-10 Finland

Cluster headache syndrome

4.1

6.4

M23.8

ICD-10 Finland

Other internal derangements of knee

2.3

6.4

255

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.9

6.4

131

R5120

NOMESCO Finland

Preparation of an aid

3.0

6.4

110

M10.9

ICD-10 Finland

Gout, unspecified

2.3

6.3

245

L04AA24

ATC

abatacept; parenteral

8.2

6.3

K92.1

ICD-10 Finland

Melaena

2.4

6.3

217

AN1

Coronary angiography

1.9

6.3

475

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

6.3

354

H02AB09

ATC

hydrocortisone; systemic

2.9

6.3

126

H02AB08

ATC

triamcinolone; systemic

18.1

6.3

M09AX01

ATC

hyaluronic acid; parenteral

2.5

6.3

182

TNE11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in sacroiliac joint

+∞

6.3

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

+∞

6.3

7242A

ICD-9 Finland

Other and unspecified disorders of back, Lumbago

+∞

6.3

72899

ICD-8 Finland

Vertebrogenic pain syndrome, Other and unspecified

+∞

6.3

SFA00

NOMESCO Finland

Small filling

1.5

6.3

187

1259

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

6.2

177

1180

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.4

6.2

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

6.2

184

1236

C05AA08

ATC

fluocortolone; rectal, topical

1.5

6.2

181

1212

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.2

6.2

R49.01

ICD-10 Finland

Functional dysphonia

2.6

6.2

165

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

6.2

104

598

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.3

6.2

233

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

6.2

113

670

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

6.2

109

637

E66.8

ICD-10 Finland

Other obesity

2.0

6.2

401

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

6.1

129

793

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

6.1

283

2087

SPAT1043

SPAT

Audiometry

1.8

6.1

539

NHG20

NOMESCO Finland

Fusion of talocrural joint

7.7

6.1

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

7.7

6.1

L83

ICPC

Neck syndrome

7.7

6.1

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.1

6.1

290

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

6.1

211

1467

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

6.1

119

720

P06

ICPC

Sleep disturbance

1.6

6.1

140

885

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

12.6

6.1

M05BA07

ATC

risedronic acid; oral

3.1

6.1

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.9

6.1

114

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

6.1

514

36400

ICD-8 Finland

Iritis, Iridocyclitis acuta

8.6

6.1

R06AX22

ATC

ebastine; oral

1.4

6.1

270

1978

C03AA03

ATC

hydrochlorothiazide; oral

1.9

6.0

484

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

6.0

155

1007

J01DA06

ATC

[U] cefuroxime; systemic

1.5

6.0

213

1488

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

6.0

179

1206

RF421

NOMESCO Finland

10.1

6.0

E000003

ATC

2.0

6.0

345

N06AX03

ATC

mianserin; oral

2.2

6.0

272

-50

ICPC

Medication/prescr/renewal

2.3

6.0

230

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.5

6.0

D02

ICPC

Abdominal pain epigastric

2.0

6.0

384

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

6.0

153

990

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013115) Eosinophils [#/volume] in Blood

1690

7904

7.48

320.10

11.3

6.0

e9/l

0.2

0.48

1621

7028

(3019198) Lymphocytes [#/volume] in Blood

1681

7873

7.31

316.28

11.3

5.8

e9/l

2.0

1.9

2.79

1615

7019

(3006315) Basophils [#/volume] in Blood

1673

7609

7.52

307.65

11.2

5.8

e9/l

0.0

2.99

1596

6644

(3001604) Monocytes [#/volume] in Blood

1671

7594

7.49

307.65

11.1

5.7

e9/l

0.6

0.92

1593

6629

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

433

480

11.17

307.65

1.6

iu/ml

0.1

0.6

0.76

106

(3013650) Neutrophils [#/volume] in Blood by Automated count

1712

8845

6.67

266.12

13.2

9.2

e9/l

3.9

4.0

0.96

1631

7776

(3008898) HLA-B27 [Presence]

386

558

8.29

262.53

1.1

—

(42870588) Differential panel, method unspecified - Blood

1215

4855

4.69

261.74

9.9

5.9

—

(3022096) Basophils/100 leukocytes in Blood

1449

6950

4.70

235.50

11.6

5.9

0.7

2.34

1415

6528

(3013707) Erythrocyte sedimentation rate by Westergren method

1889

11269

9.61

231.41

9.9

3.4

mm/h

11.5

10.4

3.42

1848

10488

(3019069) Monocytes/100 leukocytes in Blood

1476

7253

4.70

230.01

11.8

6.1

8.5

8.3

1.40

1443

6854

(3006504) Eosinophils/100 leukocytes in Blood

1467

7197

4.65

228.57

11.5

5.8

2.7

2.8

1.96

1433

6756

(3037522) Nuclear Ab [Titer] in Serum

713

2131

4.60

219.46

1.5

1.3

titre

429.8

554.5

1.28

169

433

(3002030) Lymphocytes/100 leukocytes in Blood

1484

7562

4.49

213.60

11.7

5.8

30.6

29.0

8.87

1451

7112

(3018010) Neutrophils/100 leukocytes in Blood

1466

7449

4.40

210.74

11.0

5.7

55.4

56.6

4.17

1433

7035

(40760892) CBC W Ordered Manual Differential panel - Blood

954

3769

3.86

194.89

7.5

4.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1834

11367

6.82

194.18

10.9

6.9

u/l

72.5

75.8

3.90

1799

10723

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

129

27.47

187.92

1.5

2.3

mg/l

9.5

9.9

0.17

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

225

272

9.17

175.37

4.0

3.6

56.4

56.2

0.08

225

272

(3035350) Ketones [Presence] in Urine by Test strip

1381

7308

3.73

173.14

5.2

2.9

estimate

0.0

0.80

366

1362

(3021601) Nitrite [Presence] in Urine by Test strip

1385

7363

3.72

171.92

6.6

4.1

estimate

0.0

0.32

377

1405

(3009261) Glucose [Presence] in Urine by Test strip

1390

7414

3.72

171.47

5.3

3.0

estimate

0.0

1.32

364

1341

(3037467) Urinalysis macro (dipstick) panel - Urine

1664

10329

4.24

155.29

6.2

3.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

665

2433

3.57

145.63

1.3

1.2

u/ml

7.9

11.6

0.76

294

1030

(3015736) pH of Urine

1113

5563

3.19

144.42

4.6

2.8

—

6.0

—

(3017181) Myelocytes/100 leukocytes in Blood

419

1189

4.17

131.97

5.3

4.4

0.4

1.0

4.01

309

(3029937) Albumin [Presence] in Urine by Test strip

843

3756

3.11

130.76

6.1

3.2

estimate

0.0

1.08

368

1361

(3025159) Blasts/100 leukocytes in Blood

394

1080

4.28

129.92

5.5

4.5

0.0

0.8

1.00

244

(3002179) Metamyelocytes/100 leukocytes in Blood

395

1095

4.23

128.19

4.7

4.1

0.2

0.6

5.53

234

(3021440) Promyelocytes/100 leukocytes in Blood

401

1139

4.13

125.74

5.5

4.4

0.1

0.2

1.53

288

(3021589) Normoblasts [#/volume] in Blood

1245

7015

2.97

123.77

14.5

8.3

e9/l

0.0

0.25

1121

5744

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

651

2601

3.20

120.36

1.3

1.2

iu/ml

29.7

29.4

0.01

218

828

(3011397) Hemoglobin [Presence] in Urine by Test strip

728

3114

3.07

119.39

5.0

2.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1078

5760

2.84

116.06

5.6

3.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

179

286

6.76

108.51

1.5

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

17.77

106.22

2.4

2.2

au/ml

80.5

159.9

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

16.09

105.62

2.4

2.9

mg/l

6.5

9.4

2.27

(3015171) Extractable nuclear Ab [Units/volume] in Serum

251

581

4.78

101.69

1.4

1.2

u/ml

1.6

1.0

0.25

(3021788) Differential panel - Synovial fluid

142

198

7.63

97.38

1.8

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

159

260

6.55

94.05

1.8

1.7

e6/l

9921.5

14191.9

0.56

121

191

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

887

4645

2.60

94.02

4.0

2.8

—

(3019150) Specific gravity of Urine by Refractometry

654

2954

2.78

93.27

5.8

3.2

kg/l

1.0

0.98

436

(3048689) Calprotectin [Mass/mass] in Stool

502

1985

3.02

91.48

2.9

2.4

ug/g

119.3

116.3

0.08

421

1602

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1072

6232

2.51

89.76

2.7

2.1

nmol/l

76.7

75.1

1.12

1018

5765

(3018095) Leukocytes [#/volume] in Urine

895

4804

2.53

88.82

3.8

3.1

e6/l

61.0

93.4

0.88

632

3186

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

107

122

9.20

86.49

1.8

1.6

57.9

58.7

0.06

(3017143) Hepatitis C virus Ab [Presence] in Serum

525

2233

2.82

82.74

1.4

1.6

—

(40761535) Cells panel - Urine sediment

299

913

3.66

82.63

5.7

2.9

—

(40758558) Short blood count panel - Blood

746

3797

2.52

81.46

8.2

6.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

10.08

79.12

1.7

1.5

42.1

33.2

0.94

(3044941) Cell count panel - Synovial fluid

118

171

7.26

78.02

1.6

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1987

16529

7.58

74.30

21.3

10.3

mg/l

15.1

21.8

29.47

1786

12517

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

193

466

4.47

73.56

1.8

2.1

—

(3000850) Epithelial cells [#/volume] in Urine

564

2622

2.59

73.39

2.5

2.3

e6/l

4.7

7.3

3.62

506

2275

(3018418) pH of Serum or Plasma

706

3716

2.37

69.43

3.6

3.8

7.4

0.61

170

745

(3021879) Hepatitis B virus core Ab [Presence] in Serum

378

1480

2.91

68.40

1.3

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

316

1128

3.13

67.32

2.6

2.7

g/l

10.6

10.7

0.14

289

1039

(3024561) Albumin [Mass/volume] in Serum or Plasma

939

5684

2.20

64.90

4.6

4.8

g/l

36.6

36.3

0.83

892

5307

(3034891) Synovial lining cells/100 cells in Synovial fluid

13.47

62.38

1.6

1.3

4.2

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

1791

14341

2.97

61.38

22.3

13.0

13.7

13.5

3.62

1777

14027

(3041096) Erythrocytes [Presence] in Urine by Automated

762

4336

2.21

60.47

4.5

2.7

—

(3030467) Casts [#/volume] in Urine by Automated count

658

3542

2.26

59.74

2.9

2.7

e6/l

0.2

0.4

4.25

535

2587

(36304419) Bacteria [Presence] in Urine

653

3516

2.26

59.15

2.8

2.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1005

6413

2.11

58.84

5.7

6.3

mmol/l

1.2

0.82

821

5408

(3026493) Urate [Moles/volume] in Serum or Plasma

666

3649

2.22

57.52

2.2

2.3

umol/l

2601.7

4339.9

0.71

587

3287

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

655

3623

2.19

54.76

2.3

2.0

u/l

138.3

299.3

2.67

621

3412

(3002582) Erythrocytes [#/volume] in Urine

691

3920

2.15

54.02

3.1

2.7

e6/l

100.2

126.0

0.12

572

2928

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

899

5708

2.02

51.19

5.4

5.6

mmol/l

1.2

0.02

838

5203

(4034850)

159

445

3.79

49.24

8.4

6.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

716

4258

2.05

48.26

2.5

2.4

u/l

56.3

57.7

0.18

658

3955

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

600

3349

2.12

47.92

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

594

3313

2.12

47.46

2.6

2.0

mg/l

2.9

0.17

523

2837

(3028026) IgM [Mass/volume] in Serum or Plasma

238

890

2.89

45.91

1.7

1.9

g/l

1.3

1.5

0.56

225

828

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1049

7256

1.91

44.39

4.9

6.1

umol/l

9.9

11.1

1.93

990

6894

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1069

7456

1.91

43.93

3.3

2.7

ug/l

109.2

99.6

0.59

1011

7011

(3031040) Bacteria [#/volume] in Urine by Automated count

1296

9660

1.93

43.08

4.6

3.5

e6/l

696.7

1682.9

0.47

114

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1995

17785

5.54

42.92

20.3

11.7

umol/l

71.9

72.6

0.48

1995

17779

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

134

390

3.61

39.07

1.1

1.2

—

(40761536) Microorganisms panel - Urine sediment

293

1321

2.42

38.48

4.7

3.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1996

17980

5.18

38.34

20.4

8.5

u/l

27.3

26.6

0.96

1976

17418

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

397

2048

2.16

37.80

2.3

2.4

e6/l

1.0

1.2

0.41

267

1118

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

171

596

3.04

37.22

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

393

2031

2.16

37.20

2.4

2.3

umol/l

13.1

14.1

1.64

361

1887

(3026782) Osmolality of Urine

459

2527

2.05

36.69

3.0

2.4

mosm/kgh2o

543.7

553.9

0.41

406

2137

(3010144) Erythrocytes [#/volume] in Synovial fluid

103

6.18

35.89

1.5

e6/l

3589.4

56782.3

1.10

(3036071) Salmonella sp Ab [Titer] in Serum

8.13

35.04

1.2

1.0

—

(3022145) Colonoscopy Study observation

324

1589

2.23

34.78

1.5

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

183

691

2.81

34.40

1.9

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

543

3277

1.89

32.74

1.6

1.4

g/l

2.4

2.3

0.96

391

2144

(3004789) Transferrin [Mass/volume] in Serum or Plasma

355

1862

2.10

31.93

2.3

g/l

2.4

0.16

324

1736

(3013826) Glucose [Moles/volume] in Serum or Plasma

1087

8090

1.73

31.89

4.6

4.3

mmol/l

6.4

6.6

2.31

1021

7449

(3042936) Bacteria identified in Isolate by Culture

350

1828

2.10

31.83

2.2

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

209

4.20

31.40

1.3

1.4

—

(4062490)

137

5.02

31.06

1.5

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

280

1352

2.24

31.02

2.3

2.0

nmol/l

341.1

374.0

2.06

263

1261

(3024980) IgG subclass 4 [Mass/volume] in Serum

233

3.99

31.02

1.7

1.8

g/l

0.5

0.8

2.76

176

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

330

1703

2.12

30.90

2.4

22.7

24.1

0.99

272

1481

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

198

826

2.55

30.47

1.8

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1865

16511

2.44

30.22

15.1

11.3

mmol/l

3.9

1.03

1833

15972

(3023368) Bacteria identified in Blood by Culture

517

3147

1.86

29.97

4.8

4.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1857

16434

2.38

29.69

15.0

11.2

mmol/l

139.5

139.7

3.43

1827

15936

(3020630) Protein [Mass/volume] in Serum or Plasma

202

863

2.49

29.53

2.0

2.6

g/l

68.4

67.0

1.85

182

809

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

230

1045

2.35

29.34

2.4

2.3

au/ml

25.4

20.8

0.37

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

694

4638

1.75

29.29

3.5

2.7

ng/l

136.7

46.5

0.36

405

2534

(3024139) IgG subclass 3 [Mass/volume] in Serum

138

4.83

28.85

1.6

1.4

g/l

0.4

0.21

(3028192) IgG subclass 2 [Mass/volume] in Serum

138

4.83

28.85

1.6

1.4

g/l

2.9

0.08

(3027135) IgG subclass 1 [Mass/volume] in Serum

139

4.80

28.60

1.6

1.4

g/l

6.2

6.9

0.74

(46235355) HIV 1 and 2 tests - Meaningful Use set

625

4097

1.76

27.97

1.8

1.9

—

(3024263) Appearance of Synovial fluid

7.07

27.18

2.0

2.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

211

956

2.35

27.02

1.3

au/ml

43.2

43.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

130

465

2.92

26.93

1.8

g/l

1.2

0.22

125

436

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

580

3772

1.75

26.43

1.3

u/ml

1.7

1.6

0.02

181

1074

(3044889) 12 lead EKG panel

1308

10529

1.67

26.15

3.4

3.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

356

2010

1.93

25.59

1.9

1.7

nmol/l

1388.5

1147.2

5.04

280

1557

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

109

364

3.11

25.47

2.0

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

670

4571

1.69

25.47

2.7

3.4

mmol/l

2.3

0.57

620

4131

(3021960) Folate [Moles/volume] in Serum or Plasma

447

2733

1.81

24.96

1.5

1.4

nmol/l

20.6

20.9

0.12

403

2380

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

754

5336

1.65

24.73

3.5

3.1

u/l

33.0

31.4

0.39

713

5079

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1770

15622

1.97

24.56

15.7

9.5

ml/min/173m2

90.9

88.0

8.00

1593

12784

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1527

12907

1.72

24.35

4.2

3.9

pmol/l

14.7

14.5

3.08

1426

11965

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

327

1853

1.91

23.07

1.8

1.7

—

(3032080) INR in Blood by Coagulation assay

693

4867

1.64

23.05

8.1

7.1

inr

1.1

1.2

0.43

280

1565

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

508

3300

1.72

22.71

1.8

1.7

mg/l

0.9

1.0

0.28

385

2422

(40761511) CBC panel - Blood by Automated count

1936

17789

2.59

22.64

17.9

9.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

729

5203

1.62

22.62

2.0

1.8

pmol/l

96.4

97.7

0.30

407

2814

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

382

2300

1.81

22.17

3.1

3.0

ng/l

502.4

595.9

0.13

234

1510

(3025941) Bacteria identified in Stool by Culture

189

890

2.24

22.00

1.4

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

111

410

2.81

21.67

2.2

ug/l

0.6

2.3

1.60

102

371

(3007566) Smooth muscle Ab [Titer] in Serum

118

452

2.71

21.49

1.3

titre

85.8

84.6

0.02

(40768797) Stomach Pathology biopsy report

323

1865

1.87

21.40

1.3

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

235

1219

2.05

21.31

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

5.87

20.58

1.3

1.7

u/l

5.3

6.3

0.60

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

230

1204

2.03

20.31

1.7

—

(3026008) Bacteria identified in Urine by Culture

548

3740

1.63

19.88

3.1

2.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

231

1220

2.01

19.88

2.4

2.9

1.8

0.67

214

1104

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

436

2805

1.70

19.86

1.8

1.6

pmol/l

37666208.0

36530100.9

0.01

377

2409

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

554

3834

1.61

18.83

1.9

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

361

2240

1.74

18.63

2.6

2.8

mmol/l

2.4

0.50

319

1977

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

204

1058

2.03

18.44

4.4

3.3

mmol/l

1.2

0.51

187

916

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

108

429

2.60

18.31

1.5

1.2

u/ml

4.9

47.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

144

654

2.29

18.24

1.9

2.2

u/l

39.8

38.9

0.25

130

596

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1707

15273

1.70

17.66

4.9

4.5

mu/l

1.7

2.1

2.20

1618

14248

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

241

1348

1.89

17.45

3.5

2.7

—

(3023520) Reticulocytes [#/volume] in Blood

171

851

2.10

17.25

2.2

2.9

e9/l

75.1

73.1

0.29

131

644

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

336

2.76

17.25

1.6

1.2

u/ml

27.0

33.5

0.18

(3017732) Neutrophils [#/volume] in Blood

202

1079

1.97

16.76

3.2

2.8

e9/l

4.0

0.00

172

909

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

400

2.55

16.23

1.7

1.9

g/l

7.2

0.01

308

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

400

2.55

16.23

1.7

1.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

400

2.55

16.23

1.7

1.9

g/l

3.8

0.08

289

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

379

2.58

15.99

1.7

2.0

g/l

3.1

0.09

299

(3000494) Fungus identified in Specimen by Culture

288

1748

1.75

15.90

1.5

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

231

1322

1.84

15.51

2.3

4.6

u/l

227.2

241.9

1.03

217

1264

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

393

2.51

15.32

1.5

1.2

u/ml

4.2

9.7

0.79

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

413

2791

1.60

15.06

2.7

2.9

ng/l

1200.7

1121.3

0.10

352

2315

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

325

2.65

15.05

3.2

3.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

6.83

14.87

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

265

1609

1.74

14.55

1.9

1.6

—

(3007461) Platelets [#/volume] in Blood

2011

19227

3.41

14.53

30.4

15.4

e9/l

272.3

258.4

17.95

2003

18765

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

391

2.47

14.52

1.5

1.2

u/ml

2.2

3.5

0.47

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

114

3.83

14.43

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

114

3.83

14.43

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

114

3.83

14.43

1.2

—

(3024731) MCV [Entitic volume]

2011

19242

3.37

14.21

30.2

15.4

91.1

90.3

12.95

2006

18982

(3035941) MCH [Entitic mass]

2011

19243

3.37

14.19

30.1

15.3

30.3

30.2

2.24

2005

18980

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

366

2.50

14.09

1.7

1.9

g/l

10.3

10.5

0.19

318

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

116

3.76

14.09

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

116

3.76

14.09

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

116

3.76

14.09

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

2011

19248

3.35

14.08

30.3

15.4

e12/l

4.5

4.6

10.72

2003

18747

(3010813) Leukocytes [#/volume] in Blood

2011

19252

3.34

14.00

30.4

15.5

e9/l

6.9

6.6

7.17

2001

18744

(3000963) Hemoglobin [Mass/volume] in Blood

2011

19257

3.33

13.89

30.5

15.5

g/l

135.0

136.7

7.69

2006

18988

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

872

7009

1.42

13.30

4.5

3.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

5.77

13.21

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

434

2.32

13.19

2.0

1.7

titre

160.0

423.3

0.73

(3020891) Body temperature

391

2.39

13.12

5.4

4.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

183

3.06

13.03

1.6

1.3

u/ml

9.5

56.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

187

1058

1.84

12.98

1.3

u/ml

207.2

197.9

0.04

178

980

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

239

2.78

12.88

1.3

—

60.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

293

2.58

12.70

1.4

1.2

u/ml

3.6

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

301

1966

1.62

12.45

2.6

2.5

e6/l

3.4

3.3

0.05

176

1032

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

279

2.60

12.38

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

112

545

2.12

12.00

1.7

—

(40768443) Skin Pathology biopsy report

115

568

2.09

11.85

1.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

348

2.38

11.71

2.0

g/l

0.5

0.8

0.57

309

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

184

1075

1.78

11.49

2.7

2.1

ml/min/173m2

68.2

72.9

0.61

397

(3030981) Hyaline casts [#/volume] in Urine by Automated count

122

627

2.01

11.30

2.7

2.6

e6/l

0.2

0.3

0.04

114

600

(40767503) Oxygen content in Capillary blood by calculation

227

2.69

11.30

2.2

2.3

17.0

16.8

0.10

115

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1452

12941

1.42

11.27

3.6

3.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

317

2.42

11.25

1.7

2.0

g/l

0.0

0.80

293

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

224

2.68

11.04

1.1

1.3

—

(3019060) Gas panel - Arterial blood

127

668

1.96

11.01

5.3

6.6

—

(3012544) pH of Venous blood

174

1019

1.77

10.77

3.6

—

7.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

210

2.71

10.74

1.4

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

487

2.09

10.34

3.1

2.2

1.5

1.3

0.83

482

(3002032) Base excess in Venous blood by calculation

168

988

1.76

10.26

3.7

3.5

mmol/l

2.1

1.9

0.35

140

790

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

200

1246

1.67

9.91

7.3

8.6

kpa

5.1

0.19

195

1195

(3027801) Oxygen [Partial pressure] in Arterial blood

200

1246

1.67

9.91

7.3

8.6

kpa

12.1

13.2

2.35

195

1194

(3037756) Immunofixation for Serum or Plasma

205

2.63

9.60

1.5

1.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

447

2.08

9.56

4.8

3.3

51.8

49.9

0.29

438

(3000570) Elastase.pancreatic [Mass/mass] in Stool

337

2.24

9.41

1.5

1.4

ug/g

277.8

300.2

0.37

190

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

423

2.10

9.40

2.0

2.3

mg/l

9.6

11.8

1.43

394

(40760888) Immunoglobulin light chains.free panel - Serum

214

2.56

9.33

2.5

3.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

282

1935

1.53

9.30

1.9

2.1

29.5

29.6

0.10

271

1876

(3012501) Base excess in Blood by calculation

277

2.35

9.16

2.5

3.4

mmol/l

2.6

2.4

0.25

174

(3033658) Prothrombin time (PT) actual/Normal

468

3555

1.41

9.13

3.8

3.6

95.6

94.5

0.50

453

3470

(3008152) Bicarbonate [Moles/volume] in Arterial blood

121

668

1.86

9.11

8.0

8.7

mmol/l

24.9

24.6

0.58

116

629

(3003458) Phosphate [Moles/volume] in Serum or Plasma

237

1572

1.57

9.09

4.9

6.2

mmol/l

1.1

1.0

0.42

221

1482

(3003396) Base excess in Arterial blood by calculation

197

1251

1.64

9.05

7.4

8.6

mmol/l

1.2

1.1

0.17

157

990

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1725

0.52

8.99

3.4

3.8

33.6

31.8

0.65

1227

(3024354) Oxygen [Partial pressure] in Venous blood

138

800

1.78

8.86

3.5

2.6

kpa

4.8

0.01

138

765

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

294

2.29

8.86

1.8

2.0

g/l

0.0

0.00

271

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

242

1625

1.55

8.79

2.1

2.7

umol/l

5.5

7.7

2.23

203

1421

(3012095) Magnesium [Moles/volume] in Serum or Plasma

296

2080

1.49

8.70

2.7

3.7

mmol/l

0.8

0.18

282

1961

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

317

2.22

8.62

1.8

1.9

g/l

39.3

37.9

1.14

276

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

292

2.27

8.56

1.8

2.0

g/l

0.0

0.00

270

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

515

4016

1.38

8.52

1.7

1.6

mmol/l

1.5

1.4

0.96

424

3439

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

112

618

1.86

8.46

2.6

2.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

189

2.58

8.43

1.7

1.2

—

(3010421) pH of Blood

336

2.15

8.25

2.5

3.2

7.4

2.06

271

(3009871) Measles virus Ab [Titer] in Serum

3.93

8.15

1.7

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

163

2.67

8.15

1.2

1.3

pmol/l

224.5

326.6

2.59

127

(3004809) Band form neutrophils/100 leukocytes in Blood

193

2.52

8.09

3.2

3.0

1.7

1.3

0.20

160

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.03

8.07

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

192

1250

1.59

7.97

1.7

1.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

276

2.25

7.93

2.4

3.3

ratio

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

283

2.23

7.89

2.6

3.3

mg/l

30.5

72.5

1.12

223

(3017446) Testosterone [Moles/volume] in Serum or Plasma

163

1022

1.65

7.89

2.2

nmol/l

12.9

13.0

0.03

149

937

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1578

14558

1.36

7.87

5.1

4.6

mmol/mol

37.9

38.6

2.65

1504

13682

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

490

1.92

7.76

1.8

2.0

g/l

1.5

0.07

425

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

4.53

7.65

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

4.75

7.64

1.2

1.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

140

2.75

7.62

1.4

2.3

31.9

32.3

0.15

140

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1688

15773

1.40

7.54

4.1

3.7

mmol/l

5.7

5.8

0.34

1576

14641

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

340

2518

1.42

7.54

1.8

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

390

2.01

7.51

2.5

3.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

283

2.19

7.48

2.5

3.3

mg/l

22.3

58.5

0.99

226

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

103

3.04

7.47

1.3

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

5.20

7.45

1.3

1.2

g/l

36.9

39.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

318

2.11

7.36

1.3

mmol/l

3.6

3.7

0.61

304

(3045414) Leukocytes [Presence] in Urine

108

619

1.79

7.25

1.9

1.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.41

7.25

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.08

7.17

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.08

7.17

1.3

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

320

2.07

6.88

1.4

1.5

e6/l

367.3

935.5

0.49

259

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

320

2.07

6.88

1.3

1.5

e6/l

16.5

27.8

0.30

248

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

148

2.60

6.87

1.3

nmol/l

—

(1616796) Gas panel - Central venous blood

251

2.18

6.63

2.3

3.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

184

1238

1.53

6.63

2.5

2.2

g/l

0.2

0.11

169

1166

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

157

2.51

6.61

1.3

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

135

845

1.64

6.61

3.1

3.9

ng/l

84.6

81.4

0.17

115

752

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

132

823

1.65

6.56

2.3

2.8

ng/l

79.5

170.8

5.57

123

727

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

259

2.15

6.54

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

198

1364

1.50

6.39

15.2

18.1

inr

1.2

0.14

218

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.60

6.31

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

263

2.12

6.30

1.5

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

277

2.09

6.27

1.2

1.4

—

(3047181) Lactate [Moles/volume] in Blood

368

1.93

6.20

5.7

8.5

mmol/l

1.3

1.2

0.05

319

(3003338) MCHC [Mass/volume]

1619

15153

1.33

6.19

24.9

13.1

g/l

332.0

332.9

4.10

1612

15033

(42529406) Shigella sp [Presence] in Stool by Culture

440

1.85

6.18

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

104

2.81

6.16

1.2

2.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.53

6.16

1.2

1.1

—

(3022621) pH of Urine by Test strip

139

894

1.60

6.11

3.9

2.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

435

1.85

6.09

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

431

1.84

5.95

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

363

2828

1.34

5.83

1.9

2.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.52

5.81

1.3

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

363

1.90

5.78

1.3

mg/l

494.0

504.5

0.06

350

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.90

5.62

1.1

u/l

1.4

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

12.91

5.58

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

172

1186

1.49

5.54

1.3

iu/l

25.0

27.7

0.51

143

1022

(3016650) Hepatitis A virus Ab [Presence] in Serum

299

1.97

5.47

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

135

2.47

5.46

1.2

1.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.80

5.31

1.2

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

310

1.93

5.28

1.4

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

502

4140

1.28

5.28

2.6

3.3

mmol/l

7.4

7.9

1.33

429

3578

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

221

1615

1.41

5.25

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

228

2.09

5.24

1.4

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

132

2.45

5.21

1.2

mg/l

26.3

44.7

3.60

106

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

192

1372

1.44

5.16

1.2

iu/ml

66.8

152.0

3.62

533

(3000991) Gas panel - Venous blood

140

939

1.53

5.16

7.4

8.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

115

2.54

5.13

1.2

2.1

14.4

0.00

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

146

2.35

5.09

1.1

1.2

u/l

51.7

67.6

0.66

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

225

2.07

5.04

1.5

1.6

—

(3017704) Immunofixation for Urine

3.29

5.03

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

318

1.88

4.92

1.4

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

143

2.33

4.85

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

313

1.88

4.82

1.4

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.76

4.78

1.1

nmol/l

0.1

5.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.59

4.76

1.1

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

617

1.62

4.76

9.9

12.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

1715

16330

1.31

4.75

20.2

11.2

39.9

40.4

1.50

1250

13067

(3012516) Albumin [Mass/volume] in Urine

441

3623

1.28

4.73

2.8

3.4

mg/l

1281.8

321.4

1.58

269

2324

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

171

2.19

4.69

1.2

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

139

2.32

4.69

1.3

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

198

2.09

4.66

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

240

1.98

4.61

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

490

1.68

4.60

1.1

u/ml

4.6

4.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

153

2.24

4.60

1.0

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

2.19

4.60

1.4

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

107

695

1.57

4.58

1.5

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

4.42

4.56

1.4

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

116

2.43

4.55

1.1

ratio

1.1

1.0

—

(4027681)

104

2.52

4.55

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

285

1.88

4.48

1.2

u/ml

10.3

3.5

0.51

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

123

832

1.51

4.39

2.2

2.0

ug/l

10.9

7.9

0.19

107

740

(3009214) Lutropin [Units/volume] in Serum or Plasma

568

1.61

4.36

1.3

u/l

13.7

10.0

1.15

466

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

460

1.68

4.33

1.2

1.1

—

(3012565) Volume of 24 hour Urine

2.71

4.25

1.2

2.3

2053.3

1894.7

0.29

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

120

2.35

4.25

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

262

1.89

4.23

1.1

1.2

—

(36660697) Celiac disease serology panel - Serum

179

1311

1.40

4.22

1.2

—

(40768804) Tissue Pathology biopsy report

745

6555

1.21

4.20

2.0

—

(3011412) CD3 cells [#/volume] in Blood

147

2.20

4.15

1.2

2.5

e9/l

1.3

1.2

0.26

(3048929) Epstein Barr virus Ab [Presence] in Serum

615

1.57

4.15

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

271

1.87

4.15

2.7

2.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

390

1.72

4.12

2.1

2.3

ug/l

245.5

473.8

0.82

364

(21494755) Public health laboratory ask at order entry panel

199

2602

0.74

3.97

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

192

1439

1.37

3.96

7.4

5.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

3.65

3.92

1.1

1.0

mg/g

7.6

7.0

0.07

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.90

3.90

1.1

1.0

—

(3021901) Oxygen saturation in Capillary blood

186

2.01

3.84

2.4

2.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.49

3.80

1.1

1.2

—

9.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

131

931

1.43

3.69

1.7

2.2

u/l

1689.2

6472.3

2.99

388

(3015183) Erythrocyte sedimentation rate

122

2.23

3.67

1.5

1.2

—

(3042631) Mycobacterium sp identified in Specimen

142

2.13

3.65

2.2

2.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

506

1.58

3.65

1.5

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

110

2.29

3.62

1.3

1.2

titre

314.0

262.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

104

2.32

3.59

1.2

2.0

u/field

0.5

2.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

2.41

3.56

1.6

2.4

—

(3044640) Blood type and Crossmatch panel - Blood

530

4575

1.21

3.53

2.2

2.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

451

3835

1.23

3.49

3.6

4.2

mg/mmol

11.4

8.7

0.54

271

2490

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

161

2130

0.74

3.47

1.7

—

(3049717) Cytology report of Urine Cyto stain

356

1.68

3.46

2.1

2.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

152

1122

1.38

3.46

2.9

3.4

pmol/l

4.5

0.08

135

1008

(3015235) Bicarbonate [Moles/volume] in Capillary blood

266

1.78

3.45

2.5

2.9

mmol/l

24.5

25.3

0.68

234

(3006184) Hemoglobin [Mass/volume] in Capillary blood

259

1.79

3.44

1.8

2.1

g/l

132.1

132.7

0.06

189

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

523

1.55

3.40

3.7

mmol/l

24.7

24.1

1.05

486

(3021387) Prolactin [Units/volume] in Serum or Plasma

117

828

1.44

3.39

1.8

1.7

mu/l

312.7

302.5

0.10

107

741

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.45

3.38

1.1

miu/ml

1621.0

1398.5

0.41

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

2.59

3.38

1.5

—

66.9

—

(3023419) Bacteria identified in Sputum by Culture

127

2.14

3.36

1.5

2.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

285

2313

1.27

3.34

1.6

1.8

1.5

1.4

1.09

251

2097

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.93

3.30

1.0

2.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

219

1.84

3.28

1.3

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

128

931

1.40

3.20

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

171

1.95

3.19

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

106

1472

0.70

3.10

1.3

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

306

1.68

3.09

1.3

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.24

3.06

1.5

u/l

6.6

5.8

0.11

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

175

1.90

3.00

1.4

1.5

—

(3026480) Teichoate Ab [Titer] in Serum

10.02

2.98

1.0

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

356

1.62

2.98

1.1

1.2

u/ml

254.4

273.6

0.25

227

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

176

1.89

2.96

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.15

2.93

1.1

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

296

1.67

2.91

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

281

1.69

2.90

1.2

1.1

au/ml

15.3

11.0

—

(3030313) Adrenal Ab [Titer] in Serum

6.68

2.87

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

637

1.45

2.84

1.6

1.7

—

(3003181) Sodium [Moles/volume] in Urine

158

1.91

2.80

1.7

1.4

mmol/l

66.6

65.2

0.05

133

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

378

1.58

2.79

1.1

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.47

2.79

1.3

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

124

2.03

2.76

1.2

u/ml

0.0

0.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

8.35

2.75

1.0

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.44

2.71

1.3

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

358

1.58

2.69

1.1

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.40

2.63

1.8

1.3

u/ml

22.0

20.2

—

(44813793)

106

2.09

2.63

1.1

—

(3006462) Nitrate [Presence] in Urine

2.74

2.54

5.1

1.9

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

166

0.30

2.54

11.2

13.1

nmol/l

674.6

860.4

—

159

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.51

2.53

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.83

2.47

1.9

1.7

ug/l

7.5

8.4

0.33

(3006922) Hepatitis E virus Ab [Presence] in Serum

123

1.96

2.45

1.1

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

123

1.96

2.45

1.6

2.0

nmol/l

17.9

19.2

0.35

115

(3043238) Trisomy 21 risk [Likelihood] in Fetus

629

0.61

2.43

1.5

—

(3000492) Spirometry study

206

1674

1.26

2.43

1.5

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

168

1333

1.28

2.41

2.2

u/l

38.2

76.5

0.55

135

1170

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

287

2421

1.22

2.39

3.7

3.5

22.5

21.3

0.58

120

969

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1270

12024

1.15

2.39

3.2

2.8

u/l

47.8

41.7

1.46

1206

11422

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

104

2.03

2.36

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

128

983

1.32

2.34

1.6

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

339

1.55

2.33

1.1

1.4

u/ml

104.7

105.8

0.04

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

478

1.46

2.33

2.1

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

545

1.43

2.32

2.2

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

355

3067

1.19

2.30

4.2

3.9

ug/l

2.1

0.03

327

2770

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.13

2.28

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

134

1.88

2.27

1.4

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.90

2.25

1.0

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

100

746

1.36

2.23

1.3

miu/ml

259.3

233.3

0.30

373

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.13

2.18

1.2

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.51

2.18

1.0

1.4

104.7

91.8

—

(44806118)

158

1.78

2.18

1.7

1.6

—

(44790049)

158

1.78

2.18

1.7

1.6

—

(44790048)

158

1.78

2.18

1.7

1.6

—

(44790047)

158

1.78

2.18

1.7

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1726

16761

1.19

2.16

4.1

3.7

mmol/l

4.8

0.65

1646

15861

(3047352) Trisomy 18 risk [Likelihood] in Fetus

610

0.63

2.16

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1742

16934

1.19

2.14

4.5

4.0

mmol/l

2.9

0.28

1648

15900

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

159

1.77

2.14

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

137

1.84

2.13

1.2

2.4

—

44.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

331

1.52

2.12

3.6

2.9

u/ml

0.3

0.22

180

(3005033) Fetal Nuchal fold Thickness US

606

0.64

2.11

1.4

—

(3044927) Protein electrophoresis panel - Urine

2.01

2.10

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.46

2.10

1.0

1.1

98.6

91.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

794

0.68

2.08

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

127

993

1.30

2.07

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

285

1.56

2.06

1.2

u/ml

4.1

4.3

0.03

121

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.08

2.01

1.5

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

3.34

1.96

3.7

2.0

—

(4211845)

2.36

1.95

5.1

2.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.20

1.94

1.0

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

629

1.35

1.87

1.8

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

114

1.85

1.87

1.1

1.0

—

(3013512) EKG study

414

3683

1.16

1.86

3.3

3.0

—

(1761868) Lipid panel - Serum or Plasma

665

7212

0.88

1.85

2.7

2.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

129

1.79

1.85

1.3

pmol/l

70.2

50.3

—

(3014051) Protein [Presence] in Urine by Test strip

285

1.52

1.85

2.3

2.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.54

1.84

1.7

1.4

—

(3022689) Creatine [Moles/volume] in Urine

2.51

1.83

1.2

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

115

1.83

1.1

1.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

580

1.36

1.83

9.6

10.5

mmol/l

24.1

24.3

0.25

553

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

262

1.54

1.82

1.3

1.7

—

(3023410) Appearance of Cerebral spinal fluid

160

1.70

1.82

1.2

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

369

1.45

1.80

1.1

1.4

—

16.9

—

(3000330) Specific gravity of Urine by Test strip

626

1.34

1.78

4.5

2.9

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

109

1.84

1.77

2.9

2.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

256

1.53

1.76

1.1

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.92

1.72

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

266

1.51

1.71

1.1

—

(3020650) Glucose [Presence] in Urine

2.30

1.70

2.0

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.92

1.70

1.5

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

127

1.74

1.64

2.5

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1711

16686

1.15

1.64

4.0

3.7

mmol/l

1.5

0.02

1623

15716

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.58

1.61

1.6

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

130

1058

1.24

1.59

6.7

8.2

mmol/l

8.6

8.5

0.04

125

1011

(3034274) Bile acid [Moles/volume] in Serum --fasting

280

1.47

1.57

1.8

2.3

umol/l

6.2

5.6

0.13

206

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.85

1.56

3.4

3.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

383

3433

1.14

1.55

2.3

2.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

157

0.44

1.55

1.0

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

158

0.44

1.54

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.93

1.54

4.2

3.2

u/ml

341.7

1189.8

1.92

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.43

1.53

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.43

1.53

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.43

1.53

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.43

1.53

1.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

461

1.36

1.50

3.2

3.4

g/l

0.3

0.2

0.21

194

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

731

0.73

1.48

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

730

0.73

1.47

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

730

0.73

1.47

1.3

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.37

1.45

2.9

4.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

727

0.74

1.44

1.3

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

270

1.45

1.42

3.1

3.0

umol/l

34.7

35.7

0.09

243

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

118

1.70

1.41

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

484

1.33

1.40

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

197

1.53

1.40

1.3

1.9

—

(4198724)

1.86

1.40

2.8

2.0

—

(3004451) EKG impression Narrative

2.08

1.38

1.1

1.2

—

(1002224) Polysomnography panel

107

868

1.25

1.38

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

119

1.69

1.37

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

231

1.48

1.37

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

231

1.48

1.37

1.2

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.61

1.36

12.5

6.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.61

1.36

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

103

833

1.25

1.36

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

135

1.64

1.36

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.13

1.33

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

2.13

1.33

1.0

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

388

3518

1.13

1.33

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.50

1.30

2.7

2.8

—

(4268621)

193

1.51

1.29

2.4

2.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.09

1.27

2.7

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.01

1.27

2.5

3.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.72

1.27

4.4

2.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.72

1.27

1.2

—

(3024928) Oxygen saturation in Venous blood

244

1.44

1.26

2.9

2.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.23

1.24

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

262

2328

1.14

1.23

1.5

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

147

1.57

1.23

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.05

1.22

1.2

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.64

1.21

1.2

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.80

1.21

1.4

1.8

u/field

2.3

5.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.31

1.18

1.3

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.50

1.15

4.2

7.0

—

(3017509) Phencyclidine [Presence] in Urine

2.50

1.15

1.4

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

142

1.56

1.14

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

241

1.42

1.14

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

345

1.34

1.11

1.3

1.4

u/l

24.3

25.6

0.10

291

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.73

1.09

1.5

1.4

—

828643.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1644

16098

1.11

1.08

3.7

3.4

mmol/l

1.3

0.73

1553

15121

(3001019) Free T4 and TSH panel - Serum or Plasma

118

1389

0.84

1.06

1.6

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.65

1.06

1.4

1.2

—

(4010399)

109

916

1.20

1.05

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.28

1.03

1.2

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.28

1.03

1.0

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.28

1.03

2.6

2.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.64

1.03

1.6

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

324

1.33

1.03

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.88

1.00

1.1

2.1

—

66365.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.00

1.00

2.0

1.9

ug/l

38.8

44.0

—

(40768441) Liver Pathology biopsy report

123

1.55

0.99

1.1

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.72

0.99

1.3

1.6

—

8.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.84

0.98

1.0

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.18

0.98

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

0.97

0.0

1.3

—

62.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

100

1.60

0.96

1.9

2.9

45.6

42.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.80

0.96

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

157

1.47

0.96

1.0

1.1

—

(3036489) Thrombin time

598

1.23

0.93

1.7

1.8

20.7

21.0

0.17

511

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.23

0.93

12.5

6.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.15

0.91

1.3

1.1

—

(4035726)

117

1353

0.86

0.89

1.2

1.4

—

(3000012) Reticulocyte production index

1.70

0.82

2.1

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

737

1.19

0.82

1.6

1.9

—

(3006653) Thiamine [Moles/volume] in Blood

1.65

0.81

1.0

1.4

nmol/l

144.8

126.9

0.95

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

693

1.19

0.80

3.5

3.2

kpa

5.0

5.2

0.81

651

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

312

1.29

0.79

2.2

2.7

ug/min

92.9

92.7

0.00

197

(3011897) Casein IgE Ab [Units/volume] in Serum

1.82

0.79

1.5

1.1

—

10.2

—

(3045142) Bone marrow Pathology biopsy report

149

0.60

0.79

1.2

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.67

0.78

1.0

1.8

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

0.3

—

(3000764) Benzodiazepines [Presence] in Urine

106

919

1.16

0.77

1.7

2.2

—

(3051611) Lipemic interference index of Serum or Plasma

140

1.43

0.77

2.2

3.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.09

0.74

1.6

1.4

ug/l

0.5

0.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.09

0.74

1.2

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

271

1.30

0.74

1.3

1.4

mmol/l

6.9

7.0

0.06

196

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

415

1.23

0.73

2.5

3.1

mg/l

1.5

1.4

0.38

390

(3027456) Digoxin [Moles/volume] in Serum or Plasma

150

1.40

0.73

2.4

3.1

nmol/l

0.8

0.08

122

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

380

1.24

0.72

1.3

1.5

nmol/l

0.4

0.07

299

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.58

0.71

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

106

927

1.15

0.70

1.7

2.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

126

1.43

0.70

1.0

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

418

1.23

0.70

1.2

1.1

u/ml

0.5

1.5

1.02

157

(3009343) pH of Capillary blood

685

1.17

0.69

3.5

3.2

7.4

0.41

(3027944) Amphetamines [Presence] in Urine

104

910

1.15

0.69

1.7

2.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.53

0.68

1.2

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

284

1.27

0.68

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

293

1.27

0.68

1.1

u/ml

1.4

3.4

—

174

(3028300) Cannabinoids [Presence] in Urine

106

930

1.15

0.68

1.7

2.2

—

(4024509)

120

0.58

0.67

1.6

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.54

0.67

1.4

2.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.79

0.66

3.0

1.9

—

(3051593) INR in Capillary blood by Coagulation assay

1.79

0.66

1.0

10.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.57

0.65

1.5

1.4

nmol/l

2.0

2.6

0.26

(3000093) Morphology [Interpretation] in Blood Narrative

103

1.46

0.65

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

121

1357

0.88

0.64

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.73

0.64

1.0

1.1

mg/l

0.3

195.1

—

(3025130) Human papilloma virus identified in Specimen

324

1.24

0.62

1.7

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

244

0.74

0.60

4.9

6.0

umol/l

340.7

386.7

0.74

217

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

221

2041

1.09

0.60

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

639

0.84

0.60

2.0

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.72

0.57

1.0

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

441

0.81

0.57

4.7

3.2

mmol/l

24.8

24.9

0.03

408

(3011648) Oxygen content in Venous blood

1.43

0.56

2.8

1.7

11.5

0.01

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.46

0.56

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

421

1.19

0.55

3.7

4.3

u/ml

49.4

830.0

1.22

370

(3036603) Volume of Urine

1.45

0.55

1.2

1.6

—

2244.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

801

0.87

0.53

1.9

1.7

mg/l

5.6

4.1

0.26

550

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

152

1.32

0.52

1.4

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

659

1.14

0.51

3.4

3.1

mmol/l

1.9

1.8

0.08

493

(3005988) Vibrio sp identified in Specimen by Organism specific culture

153

1.31

0.50

1.4

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

464

1.17

0.49

1.6

2.1

iu/l

4.6

4.9

0.04

189

(1761482) Bacteria [#/volume] in Urine by Culture

307

1.21

0.49

6.8

3.4

—

(40768806) Pleura Pathology biopsy report

107

0.65

0.48

1.1

1.5

—

(4306422)

282

1.21

0.46

1.2

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1.40

0.44

1.2

1.4

mmol/l

6.6

6.4

0.06

(3028679) Herpes simplex virus Ab [Presence] in Serum

104

1.35

0.43

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

350

1.17

0.42

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

350

1.17

0.42

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.38

0.41

1.4

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

228

0.79

0.41

1.1

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.41

0.0

1.3

—

(3019174) dRVVT (LA screen)

0.00

0.41

0.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.41

0.0

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.39

0.40

1.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

1.33

0.40

1.3

—

(3019225) pH of Specimen

115

1251

0.91

0.40

3.9

3.8

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.40

0.0

1.9

—

(40768795) Lymph node Pathology biopsy report

171

0.76

0.39

1.5

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.43

0.39

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.43

0.39

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

847

1.10

0.38

1.7

2.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.39

0.38

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

610

1.12

0.37

1.8

3.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

152

1.25

0.37

1.4

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.43

0.35

1.7

1.5

nmol/l

301.2

145.8

—

(3002256) Pathology report gross observation

211

1997

1.06

0.35

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

442

1.13

0.35

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

490

1.13

0.34

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

251

2391

1.06

0.34

1.6

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

264

0.83

0.33

1.5

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

360

1.14

0.32

2.3

3.2

—

(4133840)

1.28

0.32

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

324

1.14

0.30

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

157

1.21

0.29

1.4

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

311

0.87

0.27

1.1

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

159

1.20

0.26

1.4

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

159

1.20

0.26

1.4

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

702

1.09

0.26

1.8

2.2

—

(3022313) Gas panel - Capillary blood

510

0.90

0.26

4.1

3.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

281

1.14

0.26

1.1

u/ml

3.1

4.1

0.22

108

(3008757) Leukocyte morphology finding [Identifier] in Blood

123

1.22

0.25

2.1

3.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

245

1.14

0.24

1.7

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.32

0.23

1.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.23

1.0

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

313

1.12

0.23

1.1

u/ml

1.4

3.2

0.99

113

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.28

0.23

1.0

2.8

—

(3044007) Cell count panel - Peritoneal fluid

1.28

0.23

1.4

2.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.25

0.22

1.0

1.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.19

0.21

1.4

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

2.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.9

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

3.9

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.21

0.0

1.8

—

1.5

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.6

—

28.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

3.9

—

(40768800) Prostate Pathology biopsy report

156

0.83

0.21

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

102

0.78

0.21

1.4

1.6

—

(3035880) pH of Pleural fluid

1.16

0.21

1.2

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.21

0.0

2.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.21

0.0

1.3

—

10.8

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

12.2

—

128.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

129

1235

1.05

0.18

3.6

4.5

ug/l

95.9

20.8

0.38

957

(44816559) Phosphatidylethanol [Mass/volume] in Blood

352

0.91

0.18

1.2

1.4

—

(3017569) Oxygen content in Arterial blood

1.17

0.17

1.1

3.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.21

0.17

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

110

1.18

0.17

1.2

1.5

g/l

26.6

32.0

0.69

(3034426) Prothrombin time (PT)

1.11

0.17

1.3

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.73

0.17

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

152

0.85

0.17

1.5

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.13

0.16

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.20

0.16

1.2

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

168

1.13

0.15

1.1

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.13

0.15

1.1

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.13

0.15

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

634

1.06

0.15

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

381

1.08

0.15

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

131

1.15

0.14

1.1

1.0

u/ml

0.3

5.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

243

0.90

0.14

2.1

2.6

—

(40768793) Breast Pathology biopsy report

418

0.93

0.13

1.1

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

180

1.11

0.13

1.6

mmol/l

8.0

7.6

0.31

107

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.18

0.12

2.1

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

116

0.86

0.12

1.4

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

347

1.07

0.11

1.1

u/ml

0.3

2.2

—

(21494434) Karyotype in Bone marrow

105

1.14

0.11

1.2

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

177

1812

0.97

0.10

2.7

2.6

ug/l

0.7

0.45

1031

(3033799) Differential panel - Peritoneal fluid

1.14

0.10

1.4

2.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.11

0.09

1.0

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.11

0.09

1.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

203

1.08

0.09

2.3

3.1

u/ml

10.5

89.3

0.63

184

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

289

0.93

0.09

1.2

1.1

iu/ml

7.0

1675.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

107

1.12

0.08

1.2

—

(3024471) HLA-A [Type]

0.82

0.08

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.79

0.08

3.0

3.3

—

(40768446) Kidney Pathology biopsy report

0.78

0.08

2.4

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

362

1.05

0.07

1.1

u/ml

0.5

1.7

1.32

148

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.86

0.07

1.0

1.1

—

5.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.82

0.07

1.0

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.82

0.07

1.0

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.82

0.07

1.0

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.82

0.07

1.0

1.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

176

1.08

0.07

3.1

4.8

u/ml

346.4

67.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.03

0.07

1.0

1.9

—

(3045788) Cell count panel - Pleural fluid

0.86

0.07

1.3

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

893

0.97

0.07

1.5

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

152

0.92

0.06

1.4

1.3

g/l

0.9

1.0

1.59

152

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

739

0.97

0.06

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

141

0.92

0.05

1.5

1.7

—

(3051651) Icteric interference index of Serum or Plasma

101

1.09

0.04

1.5

3.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

109

0.92

0.04

4.6

6.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

180

1.06

0.04

1.1

—

(3003694) ABO and Rh group [Type] in Blood

500

4979

1.01

0.03

1.5

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

122

1.07

0.02

1.8

1.5

—

(4094501)

382

1.02

0.01

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

382

1.02

0.01

1.1

u/ml

3.4

5.6

0.59

194

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

116

0.95

0.00

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

564

1.01

0.00

1.7

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

125

0.96

0.00

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.01

0.00

1.1

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

119

1.01

0.00

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

119

1.01

0.00

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

119

1.01

0.00

1.7

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

161

0.99

0.00

1.3

1.4

—

13.1

—

(4281824)

172

0.99

0.00

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

138

1.01

0.00

1.1

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

128

1.02

0.00

1.5

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

172

0.99

0.00

1.8

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

322

0.99

0.00

3.0

3.3

mg/l

21.4

22.8

0.10

201

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

118

1.02

0.00

2.3

2.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

143

0.98

0.00

1.4

1.3

—

1.6

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.1

—

8.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.1

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.88

0.00

1.3

1.9

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

2.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.1

—

406.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

3.2

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.1

—

22.2

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

1.5

—

3319.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

4.4

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

12.2

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.1

—

37.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.90

0.00

1.0

—

3.8

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

330

1.00

0.00

1.7

1.3

ug/l

6.9

4.1

0.29

303

(3012441) Differential panel - Pleural fluid

0.96

0.00

1.2

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3013762) Body weight Measured

0.00

0.0

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.94

0.00

1.2

2.6

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.87

0.00

1.3

3.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.88

0.00

1.3

1.9

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.97

0.00

1.0

1.3

u/l

6.7

11.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SPONDYLINFLAMNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SPONDYLINFLAMNAS	1.224 [1.04, 1.44]	0.014
Birth year	1.0 [0.99, 1.01]	0.97

During the follow-up period (1.1.1998 — 31.12.2019), 297 out of 5780 females with M13_SPONDYLINFLAMNAS died.

Males

Parameter	HR [95% CI]	p-value
M13_SPONDYLINFLAMNAS	1.518 [1.31, 1.76]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 390 out of 3635 males with M13_SPONDYLINFLAMNAS died.

Mortality risk

Mortality risk for people of age

years, who have M13_SPONDYLINFLAMNAS.

N-year risk	Females	Males
1	0.084%	0.256%
5	0.817%	1.557%
10	2.133%	4.122%
15	4.094%	7.724%
20	7.452%	13.285%

Relationships between endpoints

↥

Index endpoint: M13_SPONDYLINFLAMNAS – Other specified/unspecified inflammatory spondylopathies

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other specified/unspecified inflammatory spondylopathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints